Join the Class Action Against GSK
Levi & Korsinsky, LLP is reaching out to investors of GSK plc who may have been affected by alleged securities fraud. For those unfamiliar with the situation, this class action lawsuit is focused on losses incurred between February 5, 2020, and August 14, 2022.
Understanding the Class Action Lawsuit
The lawsuit claims that GSK made misleading statements regarding their withdrawal of the drug Zantac. Allegedly, the company conveyed that it had acted based on regulatory advice and had no evidence linking their product to cancer. However, internal communications reportedly contradict these claims, leading to investor losses.
What GSK Investors Should Know
Investors who experienced financial losses in GSK during the relevant time period should act promptly. You have until April 7, 2025, to request that the court appoint you as a lead plaintiff. Importantly, sharing in any compensation does not require you to take on this role.
Your Legal Rights
Being part of the lawsuit means you might be entitled to compensation without bearing any upfront legal costs. Levi & Korsinsky operates on a contingency basis, eliminating any financial risk to participants.
GSK’s Allegations Explained
The complaint against GSK presents serious concerns. It highlights inconsistencies between their public statements and the knowledge they possessed regarding the potential health risks of Zantac. This discrepancy raises questions about corporate transparency and accountability.
Why Choose Levi & Korsinsky
With a history spanning over 20 years, Levi & Korsinsky has established a robust track record advocating for shareholders. Their skilled team boasts significant experience in securities litigation cases, providing assurance to clients about their commitment to seek justice and compensation for losses.
Trusted Representation
Being ranked among the top litigation firms in the U.S., they are well-equipped to navigate the complexities of class action lawsuits. Their expertise could be a valuable asset for those looking to participate in this legal action.
How to Get Involved
If you believe you're a victim of this alleged fraud, do not hesitate to contact Levi & Korsinsky for more information. Investors can reach out directly to Joseph E. Levi, Esq. via email or phone. It’s a chance to join forces with others who may have shared similar experiences.
Contact Information
For inquiries, individuals can contact:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Email: jlevi@levikorsinsky.com
Telephone: (212) 363-7500
Fax: (212) 363-7171
Visit: www.zlk.com
Frequently Asked Questions
What is the deadline to join the class action against GSK?
You have until April 7, 2025, to request to be appointed as a lead plaintiff in the class action lawsuit.
Who can participate in the GSK class action lawsuit?
Investors who suffered losses during the period of alleged fraud between February 5, 2020, and August 14, 2022, may participate.
Do I need to pay out-of-pocket costs to join the lawsuit?
No, there are no upfront fees or costs for participating in the class action.
What does Levi & Korsinsky offer to plaintiffs?
They provide experienced legal representation in securities litigation cases without any financial risk to investors.
How can I contact Levi & Korsinsky for more information?
You can reach Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or by phone at (212) 363-7500.
